ESTRO 2026 - Abstract Book PART I

S779

Clinical - Lung

ESTRO 2026

Manchester, Manchester, United Kingdom. 3 Department of Research and Innovation, The Christie NHS Foundation Trust, Manchester, United Kingdom. 4 School of Nursing, The Hong Kong Polytechnic University, Hong Kong, Hong Kong. 5 Christie Patient- Centred Research, The Christie NHS Foundation Trust, Manchester, United Kingdom Purpose/Objective: Digital health innovations are increasingly central to delivering patient-centred, personalised care. Integration of electronic patient-reported outcome measures (ePROMs) into routine outpatient and systemic therapy pathways has improved patient monitoring, experience, and service efficiency in our tertiary oncology centre [1]. However, the use of ePROMs for remote reporting of treatment-related side effects and providing support during radiotherapy is not well established. This project aimed to evaluate the current radiotherapy review pathway and to co- design an ePROMs-integrated pathway informed by patient and clinician feedback. Material/Methods: Data were collected over a five-week period from lung radiotherapy review clinics. Variables included appointment format (virtual, telephone, face-to-face), treatment course (radiotherapy alone or radiotherapy following chemotherapy), adverse events (graded using CTCAE V5.0), hospital admissions, and medication prescriptions. Patient and clinician engagement sessions were conducted to assess the feasibility, acceptability, and barriers to implementation of the proposed ePROMs-integrated radiotherapy review pathway. Results: Service evaluation findings from 42 radiotherapy review appointments are summarised in Table 1. Most adverse events were grade 1 (79%, 19/24). Seven patients/patient advocates participated in the patient focus group; ten clinicians participated in the clinician group. The ePROMs-integrated pathway received unanimous support.Patients highlighted key benefits such as improved communication via SMS, reassurance from automated medical advice, and greater convenience. Barriers such as digital literacy and device access were identified and are being mitigated through the use of departmental digital tablets, volunteer support, and simplified user guidance. All clinicians strongly agreed or agreed that the proposed pathway would facilitate early detection of treatment-related side effects and improve quality of care.

Conclusion: An ePROMs-integrated radiotherapy review pathway offers a scalable model to enhance patient-centred care and service efficiency during lung radiotherapy. It has the potential to replace some telephone or face- to-face reviews with ePROM-guided virtual reviews, increasing capacity and supporting wider adoption across radiotherapy services. References: [1] Nuamek T, Liao K, Price J, Taylor S, Faivre-Finn C, Yorke J. Patient-Reported Experiences of Using Electronic Patient-Reported Outcome Measures (ePROMs) as Part of Routine Cancer Care. Supportive Care in Cancer 33, S45-S431 (2025). DOI: 10.1007/s00520-025-09559-7 Keywords: ePROMs, Radiotherapy, Lung Cancer Adjuvant Thoracic Radiotherapy After Induction Chemoimmunotherapy and Surgery in Locally Advanced NSCLC: Failure Patterns and Safety Caglayan Selenge Beduk Esen 1 , Ezgi Cesur 2 , Sukran Senyurek 3 , Metin Kanitez 4 , Kerim Kaban 4 , Fatih Selcukbiricik 5 , Perran Fulden Yumuk 4 , Nil Molinas Mandel 4 , Levent Tabak 6 , Suat Erus 7 , Serhan Tanju 7 , Sukru Dilege 2 , Terman Gumus 8 , Cetin Atasoy 9 , Cengiz Demirkurek 10 , Okan Falay 11 , Mehmet Onur Demirkol 10 , Pinar Bulutay 12 , Pinar Firat 12 , Merve Duman 3 , Nulifer Kilic Durankus 3 , Saliha Ezgi Oymak 1 , Duygu Sezen 3 , Yasemin Atagun 1,3 , Ugur Selek 1,3 1 Department of Radiation Oncology, American Hospital, Istanbul, Turkey. 2 Department of Thoracic Surgery, American Hospital, Istanbul, Turkey. 3 Department of Radiation Oncology, Koc University Faculty of Medicine, Istanbul, Turkey. 4 Department of Medical Oncology, American Hospital, Istanbul, Turkey. Digital Poster 1990

Made with FlippingBook - Share PDF online